United Kingdom Allergy Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Consumables, Instruments, and Services), By Test Type (In Vivo, and In Vitro), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, and Other Allergens), and United Kingdom Allergy Diagnostics Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Allergy Diagnostics Market Insights Forecasts to 2035

• The United Kingdom Allergy Diagnostics Market Size was estimated at USD 277.54 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.83% from 2025 to 2035
• The United Kingdom Allergy Diagnostics Market Size is Expected to Reach USD 778.34 Million by 2035

According to a Research Report Published by Spherical Insights and Consulting, The United Kingdom Allergy Diagnostics Market Size is anticipated to Reach USD 778.34 Million by 2035, Growing at a CAGR of 9.83% from 2025 to 2035. The increasing use of IVD techniques, the incidence of allergy problems in youngsters and the elderly population, and easier access to diagnostic equipment are some of the key drivers propelling the market's expansion.

Market Overview

The United Kingdom Allergy Diagnostics Market Size refers to the industry focused on the development, distribution, and application of the tools, tests, and technologies used to identify allergic conditions in patients. The term "allergy" refers to an immune-driven reaction or hypersensitivity to certain chemicals, such as dust mite secretions, pollen, or pet dander. Allergy diagnostics is crucial to accurately diagnosing allergies and offering effective solutions. Common allergens include pollen, pet dander, and dust mite secretion; drug allergies include mold spores; insect allergies can range from mosquito to fruit fly bites; and food and skin allergies also occur frequently. Intradermal, skin prick, patch, and blood tests are frequently used to diagnose allergies. Recently, governments announced several schemes that boost the market expansion. For instance, Allergies are a growing public health concern in the UK, affecting nearly one-third of the population, or around 21 million citizens. The NHS currently spends an estimated £900 million to £1 billion annually managing allergic conditions. These are carried out by following steps such as primary care, specialist services, and emergency care.

Report Coverage

This research report categorizes the market for the United Kingdom allergy diagnostics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom allergy diagnostics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom allergy diagnostics market.

Driving Factors

The market for United Kingdom allergy diagnostics is influenced due to the country's explosive growth in healthcare and the substantial investments made by major market players in next-generation technology. Moreover, some of the main causes of the rising prevalence of allergy disorders are urbanization, harmful behaviors like smoking, and changing lifestyles, which are anticipated to accelerate market expansion during the forecast period. The growing use of AI and molecular diagnostics, the development of at-home care and point-of-care testing, and the rise in tailored therapies, particularly immunotherapy and targeted allergy treatments, are the main factors propelling the market's expansion. The market for allergy diagnostics is expanding and innovating, and telemedicine platforms offer an intriguing new potential.

Restraining Factors

However, the market development is being impeded by reimbursement challenges of policies in some cases, a lack of awareness of allergic conditions, and diversifications in skin, age, and immunology.

Market Segmentation

The United Kingdom allergy diagnostics market share is classified into product & service, test type, and allergen.

• The consumables segment held the largest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom allergy diagnostics market is segmented by product & service into consumables, instruments, and services. Among these, the consumables segment held the largest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. They included important items for allergy testing, including assay plates, test kits, and reagents; these are necessary for a precise and effective diagnosis. Their widespread appeal reflects the always-changing need for these products, which is being fueled by the global increase in the prevalence of allergic diseases.

• The in vivo segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The United Kingdom allergy diagnostics market is divided by testing type into in vivo, and in vitro. Among these, the in vivo segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This is due to its in vivo testing gives vital information on allergenicity by exposing patients to allergens in regulated settings and tracking their physical responses. It includes patch, skin prick, and intradermal tests that medical professionals use to accurately diagnose allergies.

• The inhaled allergens segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom allergy diagnostics market is differentiated by allergen into inhaled allergens, food allergens, drug allergens, and other allergens. Among these, the inhaled allergens segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. This is because inhaled allergens, which include dust mites, mold spores, pollen, and pet dander, are the main causes of respiratory allergies, including asthma episodes and allergic rhinitis. The market expansion of allergy diagnostics players is fueled by the constantly rising need for accurate diagnosis.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom allergy diagnostics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thermo Fisher Scientific
• Hycor Biomedical
• Siemens Healthineers
• Alk-Abello
• Inmunotek
• Omega Diagnostics
• Others

Recent Developments:

• In May 2024, Reacta Healthcare successfully wrapped up a £1 million paediatric food allergy diagnostics project, with substantial backing from Innovate UK’s Biomedical Catalyst. The initiative had focused on developing pharma-grade oral food challenge meals tailored for children as young as six months, targeting common allergens like peanut, milk, and egg.

• In June 2022, the Allergyfocus test from Oncologica was a significant advancement in allergy diagnostics. It used a simple, self-administered finger-prick blood sample to detect IgE antibodies against over 300 allergens, covering more than 99% of common global allergens. This included reactions to pollen, dust mites, pet dander, foods like nuts and shellfish, moulds, and even insect venom.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom allergy diagnostics market based on the below-mentioned segments:

United Kingdom Allergy Diagnostics Market, By Product & Service

• Consumables
• Instruments
• Services

United Kingdom Allergy Diagnostics Market, By Test Type

• In Vivo
• In Vitro

United Kingdom Allergy Diagnostics Market, By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens